share_log
Reuters ·  05/02 16:26

Arrowhead Pharmaceuticals Inc - Pursuant to 2022 Agreement With Royalty Pharma Arrowhead Is Further Eligible to Receive $110 Mln From Royalty Pharma

Arrowhead Pharmicals Inc——根据2022年与Royalty Pharma签订的协议,Arrowhead还有资格从Royalty Pharma获得1.1亿美元

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发